Institutional Biosafety Committee

The purpose of the IBC is to ensure adequate containment of potentially hazardous biological agents, to review and monitor potentially hazardous experiments, to inform the public about experimental plans that have a potential to be hazardous and to provide a means of communication among researchers and healthcare providers about potentially hazardous protocols.

Membership consists of no fewer than five members who have experience and expertise in recombinant DNA technology, the capability to assess the safety of recombinant DNA research, and to identify any potential risk to public health or the environment.  At least two members who represent the interest of the

surrounding community with respect to health and protection of the environment that are not affiliated with the institution will be on the committee.  The IBC shall include at least one individual with expertise in plant, plant pathogen, or plant pest containment principles and one scientist with expertise in animal containment principles. Members are appointed to staggered three-year terms by the Vice Chancellor for Academic Affairs and Research.  The committee elects a chair at the beginning of each year.  The IBC reports to the Associate Vice Chancellor for Research and Technology Transfer.

Glenn Bowers  (Community Rep.)                      Carole Cramer  (RDNA; Plant Patho)
 

Anthony McMickle  (Animal Containment)         Greg Phillips   (RDNA)

Maureen Dolan  (RDNA)                                   Dr. Gary Strickland (Veterinarian)

Argelia Lorence  (RDNA)